104 related articles for article (PubMed ID: 20006583)
21. Transition-state analogue gamma-secretase inhibitors stabilize a 900 kDa presenilin/nicastrin complex.
Evin G; Canterford LD; Hoke DE; Sharples RA; Culvenor JG; Masters CL
Biochemistry; 2005 Mar; 44(11):4332-41. PubMed ID: 15766262
[TBL] [Abstract][Full Text] [Related]
22. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ
Nature; 1999 Apr; 398(6727):513-7. PubMed ID: 10206644
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
Miyoshi K; Ohyagi Y; Sakae N; Motomura K; Ma L; Taniwaki T; Furuya H; Tabira T; Kira J
J Alzheimers Dis; 2009; 16(3):551-64. PubMed ID: 19276550
[TBL] [Abstract][Full Text] [Related]
24. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
De Strooper B; Annaert W; Cupers P; Saftig P; Craessaerts K; Mumm JS; Schroeter EH; Schrijvers V; Wolfe MS; Ray WJ; Goate A; Kopan R
Nature; 1999 Apr; 398(6727):518-22. PubMed ID: 10206645
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?
Knappenberger KS; Tian G; Ye X; Sobotka-Briner C; Ghanekar SV; Greenberg BD; Scott CW
Biochemistry; 2004 May; 43(20):6208-18. PubMed ID: 15147205
[TBL] [Abstract][Full Text] [Related]
26. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
27. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes.
Lee J; Song L; Terracina G; Bara T; Josien H; Asberom T; Sasikumar TK; Burnett DA; Clader J; Parker EM; Zhang L
Biochemistry; 2011 Jun; 50(22):4973-80. PubMed ID: 21528914
[TBL] [Abstract][Full Text] [Related]
28. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
29. ATF4 regulates gamma-secretase activity during amino acid imbalance.
Mitsuda T; Hayakawa Y; Itoh M; Ohta K; Nakagawa T
Biochem Biophys Res Commun; 2007 Jan; 352(3):722-7. PubMed ID: 17141186
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease.
Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y
Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123
[TBL] [Abstract][Full Text] [Related]
31. Bidirectional regulation of Aβ levels by Presenilin 1.
Bustos V; Pulina MV; Kelahmetoglu Y; Sinha SC; Gorelick FS; Flajolet M; Greengard P
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7142-7147. PubMed ID: 28533411
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II does not directly affect Aβ secretion or β-/γ-secretase activity via activation of angiotensin II type 1 receptor.
Wang BR; Shi JQ; Zhang YD; Zhu DL; Shi JP
Neurosci Lett; 2011 Aug; 500(2):103-7. PubMed ID: 21704122
[TBL] [Abstract][Full Text] [Related]
33. Insulin regulates Presenilin 1 localization via PI3K/Akt signaling.
Maesako M; Uemura K; Kubota M; Ando K; Kuzuya A; Asada M; Kihara T; Kinoshita A
Neurosci Lett; 2010 Oct; 483(3):157-61. PubMed ID: 20696212
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of PS1 is sufficient to elevate the level and activity of γ-secretase in vivo.
Li T; Li YM; Ahn K; Price DL; Sisodia SS; Wong PC
PLoS One; 2011; 6(11):e28179. PubMed ID: 22140537
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation.
Viswanathan J; Haapasalo A; Böttcher C; Miettinen R; Kurkinen KM; Lu A; Thomas A; Maynard CJ; Romano D; Hyman BT; Berezovska O; Bertram L; Soininen H; Dantuma NP; Tanzi RE; Hiltunen M
Traffic; 2011 Mar; 12(3):330-48. PubMed ID: 21143716
[TBL] [Abstract][Full Text] [Related]
36. TMP21 degradation is mediated by the ubiquitin-proteasome pathway.
Liu S; Bromley-Brits K; Xia K; Mittelholtz J; Wang R; Song W
Eur J Neurosci; 2008 Nov; 28(10):1980-8. PubMed ID: 19046380
[TBL] [Abstract][Full Text] [Related]
37. Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta.
Kuzuya A; Zoltowska KM; Post KL; Arimon M; Li X; Svirsky S; Maesako M; Muzikansky A; Gautam V; Kovacs D; Hyman BT; Berezovska O
BMC Biol; 2016 Mar; 14():25. PubMed ID: 27036734
[TBL] [Abstract][Full Text] [Related]
38. Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.
Campanari ML; García-Ayllón MS; Belbin O; Galcerán J; Lleó A; Sáez-Valero J
J Alzheimers Dis; 2014; 41(3):911-24. PubMed ID: 24699279
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.
Sogorb-Esteve A; García-Ayllón MS; Llansola M; Felipo V; Blennow K; Sáez-Valero J
Mol Neurobiol; 2018 Jun; 55(6):5047-5058. PubMed ID: 28815510
[TBL] [Abstract][Full Text] [Related]
40. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.
Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC
FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
